STAMETS STACK Trademark

Trademark Overview


On Sunday, January 12, 2025, a trademark application was filed for STAMETS STACK with the United States Patent and Trademark Office. The USPTO has given the STAMETS STACK trademark a serial number of 98954312. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Friday, June 20, 2025. This trademark is owned by MYCOMEDICA LIFE SCIENCES. The STAMETS STACK trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical, nutraceutical, and nootropic supplements and preparations, namely, supplements and preparations comprised of psilocybin, tryptamine compounds, and combinations thereof and used in conjunction with medicinal mushroom extracts, purified compounds, vitamins, adversants in the nature of niacin, capsaicin, ipecac, apomorphine, or bittering agents, and other pharmaceutical excipients for the treatment of mental health disorders, neurodegenerative disorders, inflammation, bacterial infection, or viral infection; Pharmaceutical, nutraceutical, and nootropic supplements and preparations, namely, supplements and preparations comprised of tryptamine compounds for the treatment of mental health disorders, neurodegenerative disorders, inflammation, bacterial infection, or viral infection; Nutritional supplements, namely, capsules and extracts containing mushroom mycelium and fruitbodies; and Vitamins and vitamin preparations
stamets stack

General Information


Serial Number98954312
Word MarkSTAMETS STACK
Filing DateSunday, January 12, 2025
Status638 - NEW APPLICATION - ASSIGNED TO EXAMINER
Status DateFriday, June 20, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical, nutraceutical, and nootropic supplements and preparations, namely, supplements and preparations comprised of psilocybin, tryptamine compounds, and combinations thereof and used in conjunction with medicinal mushroom extracts, purified compounds, vitamins, adversants in the nature of niacin, capsaicin, ipecac, apomorphine, or bittering agents, and other pharmaceutical excipients for the treatment of mental health disorders, neurodegenerative disorders, inflammation, bacterial infection, or viral infection; Pharmaceutical, nutraceutical, and nootropic supplements and preparations, namely, supplements and preparations comprised of tryptamine compounds for the treatment of mental health disorders, neurodegenerative disorders, inflammation, bacterial infection, or viral infection; Nutritional supplements, namely, capsules and extracts containing mushroom mycelium and fruitbodies; and Vitamins and vitamin preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, January 12, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMYCOMEDICA LIFE SCIENCES
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressShelton, WA 98584

Trademark Events


Event DateEvent Description
Sunday, January 12, 2025NEW APPLICATION ENTERED
Sunday, January 12, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 20, 2025ASSIGNED TO EXAMINER